Co-Authors
This is a "connection" page, showing publications co-authored by SHERISE DESIREE FERGUSON and ISABELLA CLAUDIA GLITZA.
Connection Strength
1.303
-
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol. 2019 May; 142(3):499-509.
Score: 0.701
-
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. 2023 04; 29(4):898-905.
Score: 0.232
-
Profiles of brain metastases: Prioritization of therapeutic targets. Int J Cancer. 2018 12 01; 143(11):3019-3026.
Score: 0.170
-
Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient. J Neurooncol. 2017 Jul; 133(3):663-665.
Score: 0.155
-
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. Cancer Discov. 2019 05; 9(5):628-645.
Score: 0.044